The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of ifebemtinib (IN10018) combined with D-1553 in non-small-cell lung cancer (NSCLC) with KRAS G12C mutation: Results from a phase Ib/II study.
 
Zhengbo Song
No Relationships to Disclose
 
XingYa Li
No Relationships to Disclose
 
Rongbo Lin
No Relationships to Disclose
 
Yuan Yuan
No Relationships to Disclose
 
Huaqiu Shi
No Relationships to Disclose
 
Ying Liu
No Relationships to Disclose
 
Yongzhong Luo
No Relationships to Disclose
 
Tangfeng Lv
No Relationships to Disclose
 
Yiping Zhang
No Relationships to Disclose
 
Yinxin Zhu
Employment - InxMed
 
Zaiqi Wang
Employment - InxMed
Stock and Other Ownership Interests - InxMed